# Mirum (MIRM) — News

MIRM · NASDAQ · Stock

Canonical page: https://www.lighthorse.io/tickers/mirm/news

## Recent headlines

- [Mirum Pharmaceuticals, Inc.: Stifel raises target price to $156 from $136](https://www.ainvest.com/news/mirum-pharmaceuticals-stifel-raises-target-price-156-136-2610) — AInvest Wire, Oct 15, 2026
- [Mirum Pharmaceuticals, Inc.: Citigroup raises target price to $184 from $160](https://www.ainvest.com/news/mirum-pharmaceuticals-citigroup-raises-target-price-184-160-2610) — AInvest Wire, Oct 13, 2026
- [Mirum Pharmaceuticals, Inc.: H.C. Wainwright raises target price to $200 from $195](https://www.ainvest.com/news/mirum-pharmaceuticals-wainwright-raises-target-price-200-195-2610) — AInvest Wire, Oct 12, 2026
  H.C. Wainwright has revised its price target for Mirum Pharmaceuticals, Inc. (NASDAQ: MRUM), raising it to $200 from the previous $195, as of October 12, 2026. The adjustment reflects the firm’s updated assessment of the company’s financial outlook and market positioning. The new target suggests a…
- [Mirum to file SNA for Livmarli in 1H 2027](https://www.ainvest.com/news/mirum-file-sna-livmarli-1h-2027-2610) — AInvest Wire, Oct 12, 2026
  Mirum Pharmaceuticals Inc. has announced its intention to file a Supplemental New Drug Application (SNA) for Livmarli (maralixibat) in the first half of 2027, according to internal planning and regulatory strategy . The SNA is expected to expand the therapeutic indications for the drug, building on…
- [Mirum Pharma shares extend gain to 13% after study data](https://www.ainvest.com/news/mirum-pharma-shares-extend-gain-13-study-data-2610) — AInvest Wire, Oct 12, 2026

---

Light Horse does not author, endorse or verify the headlines, and their appearance here is not an endorsement of any view they express.

This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.

Data provided by [AInvest](https://www.ainvest.com).